AvantGuard

Pioneering the future of long-term pathogen protection

ITHACA, United States · Founded 2018 · $2.9M raised

Headquarters
ITHACA, New York
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$2.9M
Last Round
$2.9M SeedMay 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

AvantGuard (formerly Halomine) is revolutionizing infection control with proprietary N-halamine antimicrobial technology that provides long-term protection against viruses, bacteria, and fungi/mold. Their core product Avantamine extends chlorine's pathogen-killing properties for up to 30 days on surfaces and is applied across healthcare, food processing, and hospitality industries. Founded as a Cornell University spinout, they are focused on combating Candida auris and antimicrobial resistance.

Summary

AvantGuard is a Biotech company based in ITHACA, United States, founded in 2018. It has raised $2.9M in total across 1 round, most recently a $2.9M Seed round in May 2023. Investors include Blue Ledge Capital, SOSV and Launch Ny.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMay 2023
$2.9M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AvantGuard on Indexed.vc
<a href="https://indexed.vc/companies/avantguard"><img src="https://indexed.vc/api/badge/company/avantguard" alt="AvantGuard on Indexed.vc" width="260" height="76" /></a>